Atenativ
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Atenativ, covering 2017-09-26 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass [Phase 3]